Methylmalonic Acid Test: When a Normal B12 Is Not Normal

A methylmalonic acid test measures a compound that builds up when B12 fails at its job inside the cell. It finds deficiency with a sensitivity of 98.4 percent. A serum B12 only counts the vitamin riding on any carrier in the blood. Most of it is bound to a carrier that never hands it to cells. So a normal result can hide a real deficiency.

A B12 result inside the normal range is the most common way this deficiency stays hidden. A methylmalonic acid test exists because a serum B12 level answers a narrow question. It tells you how much of the vitamin is riding on any carrier at all. It says nothing about whether your cells can use it. I walk through how B12 gets absorbed in The Normal B12 That Wasn’t, the video for The Angry Gut, Chapter 6. Here the subject is measuring. Which markers should you order? What does each one get wrong? And what does repair look like once the number is finally read right?

Why can a normal B12 level miss a deficiency?

Most of what a standard B12 test counts is bound to haptocorrin, a carrier that does not hand the vitamin to cells. The part cells actually take up rides on transcobalamin and is called holotranscobalamin. A total level is a head count of every passenger on the highway, including the ones whose car never reaches an exit.

The cutoff is older than the machines. The familiar 200 ng/L line traces to a single study. It reported 90% to 95% of deficient patients below 200, 5% to 10% between 200 and 300, and under 1% above 300. English guidance has since swapped the line for a band, calling 180 to 350 ng/L uncertain. American primary care uses the same numbers in pg/mL. Under 180 confirms it, and 180 to 350 is borderline and calls for methylmalonic acid.

Then the machine changes the verdict. On one analyzer, normal ranges sit near 182 to 692 ng/L for Asian and White patients. They sit near 225 to 1091 ng/L for Black patients. Another maker’s machine runs close to 145 to 424 ng/L. One tube of blood can be low on one machine and normal on the next.

One study tested patients with megaloblastic anemia, using methylmalonic acid as the yardstick. Total serum B12 caught 63% of the deficient, while holotranscobalamin caught 98.9%. Worse, the total level looks falsely reassuring in the very people most likely to be short. These include people with high levels of intrinsic factor antibodies, interfering antibodies, or extra haptocorrin.

What does a methylmalonic acid test measure?

Methylmalonic acid builds up when B12 fails at its job inside the cell. That makes it a function marker: it shows whether B12 is doing its job in the cell. It reports on the chemistry, not the stock. Raised more than three standard deviations above the normal average, it finds B12 deficiency with a sensitivity of 98.4%. Homocysteine, the other function marker, reaches 95.9%.

These are the cutoffs I work from. Methylmalonic acid above 280 nmol/L points to below-ideal B12 status in younger adults with healthy kidneys. Above 750 nmol/L is accepted as definite. Holotranscobalamin under 25 pmol/L means deficiency. 25 to 70 is a gray zone that needs a second marker before anyone decides.

The marker is honest about B12 and easily fooled by almost everything else. Weak kidneys raise it. So do dehydration, an underactive thyroid, and bacterial overgrowth in the small bowel that makes propionic acid. So do inherited methylmalonic aciduria and a variant in the HIBCH gene. A high reading in a dehydrated patient with weak kidneys is a question, not an answer.

Which B12 tests work best together?

A Swiss and German lab group ran four B12 markers on 3,614 routine samples. Holotranscobalamin was the best single test, with an area under the curve of 0.94. Paired with methylmalonic acid it rose to 0.98. Three-marker combinations reached 0.99. In a step-by-step method, a combined score raised the positive likelihood ratio for deficiency from 12.1 to 42.6.

The yardstick there was a formula built from the markers themselves. So read it as agreement with a formula, not with disease. The direction still holds. A function marker next to the level stops the level from misleading on its own.

What causes B12 deficiency?

A low B12 inside the cells is a downstream reading. Upstream is the first brain: a stomach lining whose parietal cells make intrinsic factor. That protein walks the vitamin to the far end of the small bowel. Lose those cells and no blood value will announce it, because the Schilling test that once measured absorption directly no longer exists.

Two biological forces do most of the damage. With Helicobacter pylori present, new atrophic gastritis develops at 5.0 times the rate seen without it. Autoimmune attack on the parietal cells does the rest. The third force is money. The calories we subsidize produce type 2 diabetes. The diabetes earns metformin. In a randomized placebo-controlled trial, metformin lowered serum B12 by 19% over 4.3 years. Acid-blocking drugs taken for two years or more carry an odds ratio of 1.65 for deficiency. Chapter 20, The Heartburn Pill You Can’t Quit, follows why so many of those prescriptions outlive their reason.

Here is the pattern a single B12 result cannot show. Iron usually goes first. When the lining of the main body of the stomach (the corpus) wastes away, iron deficiency turns up in up to half of patients. It often shows well before any B12 problem, because iron stores drain faster. In a forward-looking study of 270 patients, the lining got worse in every one, and none improved. An old low ferritin buried in a chart may be the earliest trace of a failing stomach.

Antibodies earn their place only as a pair. Anti-intrinsic factor antibody has a specificity of 100% but a sensitivity of 38%, and it tends to turn positive late. Together the two reached a sensitivity of 90% and a specificity of 95.7%. And a proton pump inhibitor raises blood gastrin three to five times. So a gastrin drawn while on the drug reports on the pill, not the stomach.

How is B12 deficiency treated once the reading is right?

The test decides the route. Passive seepage moves about 1% of an oral dose across the gut wall, even without intrinsic factor. That is why high-dose tablets are not absurd. The largest trial, 283 patients in primary care, matched shots at eight weeks but fell short across the year. 73.6% returned to normal on tablets, against 80.4% on shots. Only 10.8% of those patients had intrinsic factor antibodies. So the case for tablets rests mostly on stomachs that still work. Where the parietal cells are gone, this practice replaces the lost function by injection, for life.

The same trial holds a detail worth more than the route debate. Reaching a level above 281 pg/mL by week eight predicted success at one year, with an odds ratio of 8.10. The route itself did not, at 1.10. Load the stores, recheck early with a function marker, and read the chemistry, not the habit.

Terrain work runs alongside. Insulin resistance is the reason many people take metformin in the first place. Food, sleep and movement that lower insulin shrink the metabolic load the drug was prescribed to carry. Any change to the prescription itself goes through your physician. Where H. pylori is present, clearing it removes the driver. Much of the damage may already be past the point of no return, but clearing it still seems to lower stomach cancer risk. For why a broken metabolism undercuts every downstream fix, read why you cannot out-inject a broken metabolism.

The previous installment is Chapter 5, The Alcohol You Never Drank, and the next is Chapter 7 on what the gut wall is built from. For every study above with its full numbers and what each one does and does not show, open the Chapter 6 Deep Dive, the full evidence file with physician questions.

Frequently asked questions

What does a high methylmalonic acid level mean?

It usually means B12 is not working inside your cells, even if the blood level looks fine. Above 280 nmol/L suggests below-ideal B12 status in younger adults with healthy kidneys. Above 750 nmol/L is accepted as definite deficiency. Kidney problems, dehydration, thyroid problems and bacterial overgrowth can also raise it. So it has to be read against the rest of the chart. See how a full metabolic audit reads markers in context.

Can you be B12 deficient with a normal B12 level?

Yes. Most of the vitamin a standard test counts rides on a carrier that never delivers it to cells. In patients with megaloblastic anemia, total serum B12 caught only 63% of deficient cases when methylmalonic acid was the yardstick. The level also reads falsely normal in people with high intrinsic factor antibodies. Read what low B12 does to the brain over years.

Is holotranscobalamin a better test than serum B12?

As a single marker, yes. It measures the part of B12 bound to transcobalamin, the form cells take up. It caught 98.9% of deficient patients in a megaloblastic anemia study. Under 25 pmol/L means deficiency. 25 to 70 needs a second marker. Paired with methylmalonic acid, it sorted patients better than either test alone. Learn why a clean result and real symptoms can coexist.

Is a very high B12 level a good sign?

Not automatically. A level that stays above 1,000 pg/mL on two tests has been linked to solid tumors, blood cancers and a higher risk of death from heart and blood vessel disease. A high number is something to explain with your physician, not a reason to stop looking. It deserves the same function-marker follow-up as a low one. Explore how inflammaging changes what your body is telling you.

Is MMA high or low in B12 deficiency?

High. Methylmalonic acid builds up when B12 fails at its job inside the cell. So the level rises as B12 stops working in the cell. Raised more than three standard deviations above the normal average, it finds B12 deficiency with a sensitivity of 98.4%. Kidney problems and dehydration can also raise it. That is why a high reading is read against the rest of the chart.

How do you treat high methylmalonic acid?

Treat what the number points to. If B12 is the cause, the route depends on the stomach. High-dose tablets can work where the stomach still works. Where the parietal cells are gone, this practice replaces the lost function by injection, for life. Load the stores, then recheck early with a function marker. If the kidneys, thyroid or bacterial overgrowth drive the reading, that is where attention goes.

Sources

1. Harrington, D. J., Stevenson, E., & Sobczyńska-Malefora, A. (2024). The application and interpretation of laboratory biomarkers for the evaluation of vitamin B12 status. Annals of Clinical Biochemistry, 62(1), 22-33. https://doi.org/10.1177/00045632241292432
2. Tufail, N., Kataria, M., Chaudhary, A. J., Dhillon, R. A., Asif Naveed, M., & Mohsin, S. (2024). Comparing holotranscobalamin and total vitamin B12 in diagnosing vitamin B12 deficiency in megaloblastic anemia patients. Cureus, 16(10), e71278. https://doi.org/10.7759/cureus.71278
3. Campos, A. J., Risch, L., Nydegger, U., Wiesner, J., Dyck, M. V. V., Seger, C., Stanga, Z., Renz, H., & Risch, M. (2020). Diagnostic characteristics of 3-parameter and 2-parameter equations for the calculation of a combined indicator of vitamin B12 status to predict cobalamin deficiency in a large mixed patient population. Clinical Laboratory, 66(10). https://doi.org/10.7754/Clin.Lab.2020.200130
4. Patel, H., & McGuirk, R. (2025). Vitamin B12 deficiency: Common questions and answers. American Family Physician, 112(3), 294-300. https://pubmed.ncbi.nlm.nih.gov/40961307/
5. Osmola, M., Hémont, C., Romańczyk, M., Druet, A., Chapelle, N., Matysiak-Budnik, T., Lenti, M. V., & Martin, J. C. (2025). A comparative study of different assays for autoantibodies detection in patients with autoimmune gastritis. Journal of Translational Autoimmunity, 10, 100294. https://doi.org/10.1016/j.jtauto.2025.100294
6. Rustgi, S. D., Bijlani, P., & Shah, S. C. (2021). Autoimmune gastritis, with or without pernicious anemia: epidemiology, risk factors, and clinical management. Therapeutic Advances in Gastroenterology, 14, 17562848211038771. https://doi.org/10.1177/17562848211038771
7. Thain, A., Hart, K., & Ahmadi, K. R. (2025). Addressing the gaps in the vitamin B12 deficiency 2024 NICE guidelines: Highlighting the need for better recognition, diagnosis, and management of pernicious anaemia. European Journal of Clinical Nutrition, 79(7), 607-610. https://doi.org/10.1038/s41430-025-01583-4
8. Sanz-Cuesta, T., Escortell-Mayor, E., Cura-Gonzalez, I., Martin-Fernandez, J., Riesgo-Fuertes, R., Garrido-Elustondo, S., Mariño-Suárez, J. E., Fernández-Pacheco, J. C., Alvarez-Villalba, M., & González-González, R. (2020). Oral versus intramuscular administration of vitamin B12 for vitamin B12 deficiency in primary care: a pragmatic, randomised, non-inferiority clinical trial (OB12). BMJ Open, 10(8), e033687. https://doi.org/10.1136/bmjopen-2019-033687
9. Shah, S. C., Piazuelo, M. B., Kuipers, E. J., & Li, D. (2021). AGA Clinical Practice Update on the Diagnosis and Management of Atrophic Gastritis: Expert Review. Gastroenterology, 161(4), 1325-1332.e7. https://doi.org/10.1053/j.gastro.2021.06.078
10. Lam, J. R., Schneider, J. L., Zhao, W., & Corley, D. A. (2013). Proton pump inhibitor and histamine 2 receptor antagonist use and vitamin B12 deficiency. JAMA, 310(22), 2435-2442. https://doi.org/10.1001/jama.2013.280490

Medically reviewed by Dr. Gurpreet Singh Padda, MD, MBA, MHP, board certified in anesthesiology, pain medicine, interventional pain management, addiction medicine and obesity medicine. Adapted from Chapter 6 of The Angry Gut by Dr. Padda and Ami Michelle Grimes. Last reviewed September 2026.